Market Closed -
Bombay S.E.
06:00:58 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
818.6
INR
|
-0.41%
|
|
+2.20%
|
-6.07%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,808
|
1,144
|
810.8
|
1,514
|
2,568
|
8,075
|
Enterprise Value (EV)
1 |
2,747
|
2,166
|
1,634
|
2,293
|
3,409
|
8,165
|
P/E ratio
|
26.7
x
|
33
x
|
7.21
x
|
8.71
x
|
7.8
x
|
11.5
x
|
Yield
|
1.26%
|
1.19%
|
2.8%
|
1.8%
|
1.41%
|
0.84%
|
Capitalization / Revenue
|
0.53
x
|
0.38
x
|
0.24
x
|
0.38
x
|
0.51
x
|
1.43
x
|
EV / Revenue
|
0.8
x
|
0.71
x
|
0.48
x
|
0.58
x
|
0.67
x
|
1.44
x
|
EV / EBITDA
|
9.06
x
|
6.91
x
|
4.28
x
|
4.91
x
|
5.36
x
|
7.17
x
|
EV / FCF
|
27.7
x
|
46.4
x
|
5.38
x
|
-24.2
x
|
-26.4
x
|
11.8
x
|
FCF Yield
|
3.61%
|
2.16%
|
18.6%
|
-4.13%
|
-3.79%
|
8.5%
|
Price to Book
|
1.33
x
|
0.76
x
|
0.53
x
|
0.88
x
|
1.28
x
|
3.02
x
|
Nbr of stocks (in thousands)
|
9,079
|
9,079
|
9,079
|
9,079
|
9,079
|
9,079
|
Reference price
2 |
199.2
|
126.0
|
89.30
|
166.8
|
282.9
|
889.4
|
Announcement Date
|
18-07-11
|
19-07-18
|
20-07-13
|
21-07-07
|
22-07-13
|
23-07-12
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,416
|
3,030
|
3,422
|
3,963
|
5,060
|
5,658
|
EBITDA
1 |
303.2
|
313.3
|
381.5
|
467
|
636.5
|
1,139
|
EBIT
1 |
154.9
|
166.4
|
227.7
|
313.8
|
496
|
1,002
|
Operating Margin
|
4.53%
|
5.49%
|
6.65%
|
7.92%
|
9.8%
|
17.71%
|
Earnings before Tax (EBT)
1 |
119.6
|
73.3
|
134.1
|
253.2
|
491.6
|
990.7
|
Net income
1 |
67.78
|
34.71
|
112.4
|
173.9
|
329.2
|
703.1
|
Net margin
|
1.98%
|
1.15%
|
3.29%
|
4.39%
|
6.51%
|
12.43%
|
EPS
2 |
7.465
|
3.820
|
12.38
|
19.15
|
36.26
|
77.44
|
Free Cash Flow
1 |
99.23
|
46.69
|
303.9
|
-94.64
|
-129.3
|
693.6
|
FCF margin
|
2.91%
|
1.54%
|
8.88%
|
-2.39%
|
-2.56%
|
12.26%
|
FCF Conversion (EBITDA)
|
32.73%
|
14.9%
|
79.65%
|
-
|
-
|
60.89%
|
FCF Conversion (Net income)
|
146.4%
|
134.5%
|
270.33%
|
-
|
-
|
98.65%
|
Dividend per Share
2 |
2.500
|
1.500
|
2.500
|
3.000
|
4.000
|
7.500
|
Announcement Date
|
18-07-11
|
19-07-18
|
20-07-13
|
21-07-07
|
22-07-13
|
23-07-12
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
939
|
1,021
|
823
|
779
|
841
|
90
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.095
x
|
3.259
x
|
2.156
x
|
1.668
x
|
1.321
x
|
0.079
x
|
Free Cash Flow
1 |
99.2
|
46.7
|
304
|
-94.6
|
-129
|
694
|
ROE (net income / shareholders' equity)
|
2.84%
|
3.25%
|
7.98%
|
10.8%
|
18.3%
|
30.8%
|
ROA (Net income/ Total Assets)
|
3.25%
|
3.36%
|
4.67%
|
6.53%
|
9.51%
|
17.6%
|
Assets
1 |
2,088
|
1,034
|
2,406
|
2,663
|
3,463
|
4,002
|
Book Value Per Share
2 |
150.0
|
166.0
|
169.0
|
191.0
|
221.0
|
295.0
|
Cash Flow per Share
2 |
3.500
|
4.960
|
1.500
|
1.020
|
2.310
|
33.30
|
Capex
1 |
154
|
173
|
100
|
78.1
|
152
|
216
|
Capex / Sales
|
4.51%
|
5.72%
|
2.94%
|
1.97%
|
3%
|
3.82%
|
Announcement Date
|
18-07-11
|
19-07-18
|
20-07-13
|
21-07-07
|
22-07-13
|
23-07-12
|
|
1st Jan change
|
Capi.
|
---|
| -6.07% | 89.29M | | +2.11% | 102B | | -11.98% | 58.85B | | +72.38% | 47.79B | | +8.17% | 36.9B | | +0.90% | 31.19B | | +4.63% | 18.85B | | +13.88% | 17.05B | | +5.77% | 13.95B | | -5.51% | 13.14B |
Other Commodity Chemicals
|